(Q41641498)

English

Growth inhibition of human pancreatic cancer cells by cholecystokinin receptor antagonist in tissue culture and in nude mice

scientific article published on February 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 October 2017

Growth inhibition of human pancreatic cancer cells by cholecystokinin receptor antagonist in tissue culture and in nude mice (English)

1 reference

Europe PubMed Central

6 October 2017

cholecystokinin

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

A Funakoshi

1

1 reference

Europe PubMed Central

6 October 2017

A Kono

2

1 reference

Europe PubMed Central

6 October 2017

publication date

1 February 1992

1 reference

Europe PubMed Central

6 October 2017

Gastroenterologia Japonica

1 reference

Europe PubMed Central

6 October 2017

27

1 reference

Europe PubMed Central

6 October 2017

1

1 reference

Europe PubMed Central

6 October 2017

78-82

1 reference

Europe PubMed Central

6 October 2017

Establishment of a New Human Pancreatic Adenocarcinoma Cell Line, MDAPanc-3

1 reference

https://pubmed.ncbi.nlm.nih.gov/1555749

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/1555749

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium

1 reference

https://pubmed.ncbi.nlm.nih.gov/1555749

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1555749

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/1555749

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment and characterization of human pancreatic cancer cell lines in tissue culture and in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/1555749

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticholecystokinin activities of loxiglumide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1555749

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastrointestinal hormones and gastrointestinal and pancreatic carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/1555749

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/1555749

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differentiation features of human pancreatic tumor cells maintained in nude mice and in culture: immunocytochemical and ultrastructural studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/1555749

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02775067

0 references

1 reference

Europe PubMed Central

6 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41641498&oldid=1967287621"